drugset / Trial / NCT05503043

Effect of Intravenous Lidocaine on Serum miRNA-135a in Patients Undergoing Non-cardiac Surgery

NCT05503043 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to investigate the effects of intravenous lidocaine on serum miRNA-135a and its downstream proteins Rock2 and Add1 in elderly patients undergoing non-cardiac under general anesthesia.

Timeline

Start
2022-09-01
Primary completion
2023-09-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.7 mg/kg Intravenous

Indications

No indication recorded.